Changes in bone resorption during the menstrual cycle

To determine if the cyclic changes of female sex hormones during the menstrual cycle are related to changes in bone formation and resorption, we measured serum bone-specific alkaline phosphatase (BAP) and osteocalcin (OC) and bone resorption markers, serum and urine deoxypyridinoline (Dpyr), three times per week during one menstrual cycle in 20 healthy premenopausal women. Serum estradiol (E-2) and progesterone (P) showed characteristic cyclic fluctuations. Serum Dpyr was higher during the follicular phase (FP) than in the luteal phase (p = 0.027), Serum BAP, OC, and urine Dpyr levels did not change substantially across the cycle. Serum Dpyr correlated negatively with serum E-2 values measured 6 (p = 0.011) and 8 (p = 0.001) days earlier and with P measured concurrently (p = 0.033) 2 (p = 0.002), 4 (p = 0.003), and 6 (p = 0.014) days earlier. BAP correlated negatively with E-2 measured 6 days earlier (p = 0.006). We found no statistically significant correlations of E-2 or P with OC or urine Dpyr within women over their cycles, BAP was positively correlated with concurrent serum Dpyr (p = 0.015) during the menstrual cycle, Serum OC levels correlated inversely with age (r(s) = -0.48, p = 0.036). Women with higher mean urine Dpyr levels had higher mean serum OC levels (r(s) = 0.49, p = 0.033) and showed a trend toward lower hip bone mineral density (r(s) = -0.40, p = 0.078). We conclude that the low level of E-2 and/or P observed during the FP of the normal menstrual cycle is associated with increased bone resorption. These relationships suggest that normal women experience monthly episodes of increased bone resorption from menarche to menopause.